152 related articles for article (PubMed ID: 12374894)
1. New treatments for myocardial fibrosis.
Sanderson JE
Cardiovasc Drugs Ther; 2002 May; 16(3):181-2. PubMed ID: 12374894
[No Abstract] [Full Text] [Related]
2. Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
Cittadini A; Casaburi C; Monti MG; Di Gianni A; Serpico R; Scherillo G; Saldamarco L; Vanasia M; Saccà L
Cardiovasc Drugs Ther; 2002 May; 16(3):195-201. PubMed ID: 12374896
[TBL] [Abstract][Full Text] [Related]
3. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
Aaronson K
Health News; 2003 May; 9(5):4. PubMed ID: 12739453
[No Abstract] [Full Text] [Related]
4. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.
Zannad F; Dousset B; Alla F
Hypertension; 2001 Nov; 38(5):1227-32. PubMed ID: 11711528
[TBL] [Abstract][Full Text] [Related]
5. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
[No Abstract] [Full Text] [Related]
6. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
[No Abstract] [Full Text] [Related]
7. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
8. [Aldosterone blockade in heart failure. So much for so little].
González-Juanatey JR; Mazón Ramos P
Med Clin (Barc); 2002 Jun; 118(20):779-81. PubMed ID: 12049694
[No Abstract] [Full Text] [Related]
9. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
Ajani AE; Marwick TH; Krum H
Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870
[TBL] [Abstract][Full Text] [Related]
10. [The EMPHASIS-HF study].
Boccanelli A; Agostoni P
G Ital Cardiol (Rome); 2011 May; 12(5):315-8. PubMed ID: 21593949
[No Abstract] [Full Text] [Related]
11. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
Bauersachs J; Ertl G
Med Klin (Munich); 2006 Jun; 101(6):458-66. PubMed ID: 16767569
[TBL] [Abstract][Full Text] [Related]
12. New treasures from old? EPHESUS. Eplerenome Post-AHI Heart Failure Efficacy and Survival Study.
Pfeffer MA
Cardiovasc Drugs Ther; 2001 Jan; 15(1):11-3. PubMed ID: 11504157
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone antagonism in heart failure.
Richards AM; Nicholls MG
Lancet; 1999 Sep; 354(9181):789-90. PubMed ID: 10485716
[No Abstract] [Full Text] [Related]
14. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
Dawson A; Davies JI; Struthers AD
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
[TBL] [Abstract][Full Text] [Related]
15. [Decrease in mortality on spironolactone being added to the conventional treatment of heart failure].
Soto Alvarez J
Aten Primaria; 2000 Mar; 25(4):282-4. PubMed ID: 10795447
[No Abstract] [Full Text] [Related]
16. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs.
Armanini D; Sabbadin C; Donà G; Clari G; Bordin L
Expert Opin Pharmacother; 2014 May; 15(7):909-12. PubMed ID: 24617854
[TBL] [Abstract][Full Text] [Related]
18. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
Pitt B; Williams G; Remme W; Martinez F; Lopez-Sendon J; Zannad F; Neaton J; Roniker B; Hurley S; Burns D; Bittman R; Kleiman J
Cardiovasc Drugs Ther; 2001 Jan; 15(1):79-87. PubMed ID: 11504167
[No Abstract] [Full Text] [Related]
19. Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?
Struthers AD
Br J Clin Pharmacol; 1999 May; 47(5):479-82. PubMed ID: 10336570
[No Abstract] [Full Text] [Related]
20. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.
Cittadini A; Monti MG; Isgaard J; Casaburi C; Strömer H; Di Gianni A; Serpico R; Saldamarco L; Vanasia M; Saccà L
Cardiovasc Res; 2003 Jun; 58(3):555-64. PubMed ID: 12798428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
